R. Oakes

2.3k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

R. Oakes is a scholar working on Clinical Psychology, Experimental and Cognitive Psychology and Psychiatry and Mental health. According to data from OpenAlex, R. Oakes has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Clinical Psychology, 7 papers in Experimental and Cognitive Psychology and 4 papers in Psychiatry and Mental health. Recurrent topics in R. Oakes's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (7 papers), Perfectionism, Procrastination, Anxiety Studies (5 papers) and Mental Health Research Topics (3 papers). R. Oakes is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (7 papers), Perfectionism, Procrastination, Anxiety Studies (5 papers) and Mental Health Research Topics (3 papers). R. Oakes collaborates with scholars based in United States, United Kingdom and Netherlands. R. Oakes's co-authors include Cornelius D. Pitts, Janet B. McGill, Jackson T. Wright, George L. Bakris, Philip Raskin, Vivian Fonseca, David S.H. Bell, Franz H. Messerli, Robert A. Phillips and Mary Ann Lukas and has published in prestigious journals such as JAMA, Gastroenterology and American Journal of Psychiatry.

In The Last Decade

R. Oakes

14 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension

2004 536 citations George L. Bakris, Vivian Fonseca et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Oakes United States	9	426	362	304	249	209	16	1.1k
Conrad M. Swartz United States	21	297 0.7×	903 2.5×	75 0.2×	554 2.2×	141 0.7×	115	1.4k
Edmund P. Harrigan United States	12	471 1.1×	893 2.5×	79 0.3×	163 0.7×	408 2.0×	28	1.6k
Ida Kim Wium‐Andersen Denmark	13	168 0.4×	165 0.5×	186 0.6×	153 0.6×	74 0.4×	43	841
Harvey Sternbach United States	12	265 0.6×	789 2.2×	186 0.6×	581 2.3×	142 0.7×	23	1.3k
D Pittrow Germany	14	448 1.1×	81 0.2×	255 0.8×	135 0.5×	32 0.2×	45	1.1k
Wendy Arnott Canada	8	130 0.3×	711 2.0×	68 0.2×	150 0.6×	135 0.6×	11	972
Marjaana Koponen Finland	24	198 0.5×	762 2.1×	69 0.2×	158 0.6×	87 0.4×	81	1.6k
A. Anderson Australia	15	152 0.4×	166 0.5×	42 0.1×	266 1.1×	78 0.4×	27	937
Subramoniam Madhusoodanan United States	21	54 0.1×	779 2.2×	123 0.4×	220 0.9×	175 0.8×	62	1.5k
Jonathan M. Meyer United States	10	203 0.5×	1.4k 3.8×	679 2.2×	116 0.5×	131 0.6×	13	1.9k

Countries citing papers authored by R. Oakes

Since Specialization

Citations

This map shows the geographic impact of R. Oakes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Oakes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Oakes more than expected).

Fields of papers citing papers by R. Oakes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Oakes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Oakes. The network helps show where R. Oakes may publish in the future.

Co-authorship network of co-authors of R. Oakes

This figure shows the co-authorship network connecting the top 25 collaborators of R. Oakes. A scholar is included among the top collaborators of R. Oakes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Oakes. R. Oakes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Oakes, R., et al.. (2024). Hematological and immunological profiles of podoconiosis patients in West Gojjam Zone, Ethiopia: A comparative cross-sectional study. PLoS neglected tropical diseases. 18(12). e0012732–e0012732.

Shah, P.J.R., W W Dinsmore, R. Oakes, & Geoff Hackett. (2007). Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate. Current Medical Research and Opinion. 23(10). 2577–2583. 18 indexed citations

Bakris, George L., Vivian Fonseca, Richard E. Katholi, et al.. (2004). Metabolic Effects of Carvedilol vs Metoprolol in Patients With Type 2 Diabetes Mellitus and Hypertension. JAMA. 292(18). 2227–2227. 536 indexed citations breakdown →

Hollander, Eric, Andrea Allen, Martin Steiner, et al.. (2003). Acute and Long-Term Treatment and Prevention of Relapse of Obsessive-Compulsive Disorder With Paroxetine. The Journal of Clinical Psychiatry. 64(9). 1113–1121. 93 indexed citations

Liebowitz, Michael R., Murray B. Stein, Manuel E. Tancer, et al.. (2002). A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo in the Treatment of Generalized Social Anxiety Disorder. The Journal of Clinical Psychiatry. 63(1). 66–74. 95 indexed citations

Stein, Dan J., et al.. (2002). Paroxetine in social anxiety disorder: A remission analysis. European Neuropsychopharmacology. 12. 347–348. 2 indexed citations

Nemeroff, Charles B., Dwight L. Evans, L. Gyulai, et al.. (2001). Double-Blind, Placebo-Controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar Depression. American Journal of Psychiatry. 158(6). 906–912. 269 indexed citations

Palmer, Robert H., et al.. (2000). Nabumetone is associated with fewer endoscopic ulcers and fewer bleeding lesions than oxaprozin in elderly patients with osteoarthritis. Gastroenterology. 118(4). A252–A252.

Dean, Jason W., et al.. (1999). A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction. International Journal of Impotence Research. 11(2). 91–97. 31 indexed citations

10.

Stein, Dan J., Michael Berk, Charl Els, et al.. (1999). A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.. PubMed. 89(4). 402–6. 23 indexed citations

11.

Montgomery, S.A., et al.. (1998). Paroxetine in severe social phobia. European Psychiatry. 13(S4). 237s–238s. 1 indexed citations

12.

Gergel, I., et al.. (1997). Significant improvement in symptoms of social phobia after paroxetine treatment. Biological Psychiatry. 42(1). 26S–26S. 7 indexed citations

13.

Judge, R., Daniel B. Burnham, Martin Steiner, et al.. (1996). Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: A double-blind study. European Psychiatry. 11. 346s–347s. 8 indexed citations

14.

Judge, R., et al.. (1996). P-46 Paroxetine long-term safety and efficacy in panic disorder and prevention of relapse: A double blind study. European Neuropsychopharmacology. 6. S26–S26. 5 indexed citations

15.

Kreider, Margaret S., et al.. (1995). A double-blind, randomized study to provide safety information on switching fluoxetine-treated patients to paroxetine without an intervening washout period.. PubMed. 56(4). 142–5. 12 indexed citations

16.

Dunbar, G., Marcelo Luis Steiner, R. Oakes, et al.. (1995). P-5-26 A fixed dose study of paroxetine (10 mg, 20 mg, 40 mg) and placebo in the treatment of panic disorder. European Neuropsychopharmacology. 5(3). 361–361. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact